OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Lin on CAR T-Cell Therapy–Related Toxicities in Multiple Myeloma

January 13th 2021

Yi Lin, MD, PhD, discusses CAR T-cell therapy–related toxicities in multiple myeloma.

Dr. Sullivan on Sequencing Targeted Therapy and Immunotherapy in Melanoma

January 13th 2021

Ryan Sullivan, MD, discusses treatment sequencing with targeted therapy and immunotherapy in melanoma.

Dr. Janjigian on the Importance of Routine HER2 Testing in Gastric/GEJ Cancer

January 13th 2021

Yelena Y. Janjigian, MD, discusses the importance of routine HER2 testing in gastric/gastroesophageal cancer.

Dr. Fonseca on the Emergence of MRD in Multiple Myeloma

January 13th 2021

Rafael Fonseca, MD, discusses the emergence of minimal residual disease in multiple myeloma.

Dr. Schweizer on the Results of the HERO Trial in Prostate Cancer

January 13th 2021

Michael Schweizer, MD, discusses the results of the HERO trial in prostate cancer.

Dr. DeAngelo on the Utility of Moxetumomab Pasudotox in HCL

January 13th 2021

Daniel J. DeAngelo, MD, PhD, discusses the utility of moxetumomab pasudotox-tdfk in hairy cell leukemia.

Dr. Strosberg on the Need for Additional Targeted Therapies in HCC

January 12th 2021

Jonathan R. Strosberg, MD, discusses the need to develop additional targeted therapies in hepatocellular carcinoma.

Dr. Chalabi on the Importance of Testing for MSI and dMMR in CRC

January 12th 2021

Myriam Chalabi, MD, highlights the importance of testing for microsatellite instability and mismatch repair deficiency in colorectal cancer.

Dr. Braunstein on the Role of Daratumumab in Multiple Myeloma

January 12th 2021

Marc J. Braunstein, MD, PhD, discusses the role of daratumumab in multiple myeloma.

Dr. Shah on the Rationale for Tandem Receptor CAR T-Cell Therapy in Non-Hodgkin Lymphoma

January 11th 2021

Nirav N. Shah, MD, discusses the rationale to evaluate tandem receptor CAR T-cell therapy in non-Hodgkin lymphoma.

Dr. Gomella on the Role of Genetic Testing in Prostate Cancer

January 11th 2021

Leonard G. Gomella, MD, discusses the role of genetic testing in prostate cancer.

Dr. Puechl on Choosing Between PARP Inhibitors in Ovarian Cancer

January 11th 2021

Allison M. Puechl, MD, discusses choosing between PARP inhibitors in ovarian cancer.

Dr. Hutson on Challenges With Targeted Therapy in Non-Clear Cell RCC

January 8th 2021

Thomas Hutson, DO, PharmD, discusses challenges with targeted therapy in non-clear cell renal cell carcinoma.

Dr. Campbell on the Impact of the COVID-19 Pandemic in RCC

January 8th 2021

Matthew T. Campbell, MD, MS, discusses the impact of the coronavirus disease 2019 pandemic in renal cell carcinoma.

Dr. Lee on the Tolerability of Ibrutinib/Cirmtuzumab in MCL and CLL

January 8th 2021

Hun Ju Lee, MD, discusses the tolerability of ibrutinib plus cirmtuzumab in mantle cell lymphoma and chronic lymphocytic lymphoma.

Dr. Kumar on Sequencing Selinexor-Based Combinations in Multiple Myeloma

January 8th 2021

Shaji K. Kumar, MD, discusses sequencing selinexor-based combinations in relapsed/refractory multiple myeloma.

Dr. Chauhan on Future Directions With Lutathera in GEP-NETs

January 8th 2021

Aman Chauhan, MD, discusses future directions with Lutathera in gastroenteropancreatic neuroendocrine tumors.

Dr. Mai on Guidelines for Genetic Testing in CRC

January 8th 2021

Phuong L. Mai, MD, discusses guidelines for genetic testing in colorectal cancer.

Hussain and Taplin Talk Gender-Specific Struggles, Career Lessons in GU Oncology

January 8th 2021

Maha H.A. Hussain, MD, and Mary-Ellen Taplin, MD, sit down with OncLive® to travel the road that led them to specialize in genitourinary oncology, the challenges they experienced as a female in the field, and advice they would give to not only other rising female oncologists, but to their younger selves knowing what they know now.

Dr. Braunstein on Management Strategies in Multiple Myeloma

January 7th 2021

Marc J. Braunstein, MD, PhD, discusses management strategies in multiple myeloma.